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Background: Human parainfluenza virus type 3 (HPIV3), while infecting lower airway epithelial cells induces
pneumonia and bronchiolitis in infants and children, and may lead to asthma exacerbations in children and adults.
Respiratory viruses invading the airway epithelium activate innate immune response and induce inflammatory
cytokine release contributing to the pathophysiology of upper and lower airway disorders. However, the effects of
HPIV3 infection on nasal epithelial cells have not been well defined.
The aim of this study was to evaluate the effect of the HPIV3 infection on cultured human nasal epithelial cells
(HNECs) and the release of interferon gamma and other cytokines.
Methods: RPMI 2650, a human nasal epithelial cell line was cultured into confluence and was infected with HPIV3
(MOI of 0.1, 0.01 and 0.001). The protein release into supernatants and mRNA expression of selected cytokines were
assessed 24, 48 and 72 h after infection. Cytokine concentrations in supernatants were measured by ELISA and
expression of cytokine mRNA in RPMI 2650 cells confirmed by real time RT-PCR analysis.
Results: HNECs infection with HPIV3 did not induce cytotoxicity for at least 48 hours, but significantly increased
IFN-γ protein concentration in the cell supernatants at 24 h and 48 h post infection (by 387% and 485% respectively
as compared to mock infected cells). At 24 h a significant increase in expression of mRNA for IFNγ was observed.
RANTES protein concentration and mRNA expression were significantly increased at 72 h after infection (mean
protein concentration: 3.5 ± 1.4 pg/mL for 0.001 MOI, 10.8 ± 4.6 pg/mL for 0.01 MOI and 61.5 ± 18.4 pg/mL for 0.1
MOI as compared to 2.4 ± 1.3 pg/mL for uninfected cells). No measurable concentrations of TNF-α, IL-10, TSLP, IL-8,
GM-CSF or eotaxin, were detected in virus infected cells supernatants.
Conclusions: HPIV3 effectively infects upper airway epithelial cells and the infection is associated with induction of
IFN-γ and generation of RANTES.
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Human parainfluenza viruses (HPIVs) which belong to the
family Paramyxoviridae are enveloped, negative-strand
RNA viruses and are common cause of acute airway re-
spiratory illness in children and adults [1]. Out of four rec-
ognized serotypes PIV1 and PIV2 are leading causes of* Correspondence: marek.kowalski@csk.umed.lodz.pl
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article, unless otherwise stated.laryngotracheobronchitis in children, while PIV4 is a com-
mon respiratory pathogen similar to PIV3 in clinical pres-
entation [2]. PIV3 is usually associated with bronchiolitis
and pneumonia, and is among the most common cause of
hospitalization in children [3-6]. In addition both in chil-
dren and adults PIV3 infections have been implicated in
exacerbation of bronchial asthma [7,8]. HPIV infection
usually starts in the nose, and then spreads to the par
nasal sinuses, Eustachian tubes, larynx, and eventually to
the lower airways [9]. In upper airways of healthy adults
the HPIV infection usually causes mild and transientMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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acerbation of chronic upper airway diseases (rhino sinus-
itis) is largely unknown. In one study PIV3 was detected
in HNECs from 88% of patients with post viral olfactory
dysfunction as compared to 9% of control patients [10]
suggesting potential involvement of PIV3 infection into
the upper airway pathology.
Airway epithelium is the first line of defense during re-
spiratory infection, and viral infection of lower airway
epithelium with human respiratory viruses (rhinovirus,
RSV or influenza) induce generation of a variety of cyto-
kines, chemokines and interferons (including IFNs type I
(α, β) or type III (λ) ), which are involved in the host
defense and development of the airway inflammation
[11-14]. However, few published studies evaluated para-
influenza virus interaction with the airway epithelium
and little is known about the upper airway epithelial re-
sponse to HPIVs infection [15,16].
Type I and type III, but not type II interferon (IFN-γ)
are the predominant interferons induced by respiratory vi-
ruses in nasal epithelial cells [17]. IFN-γ is a cytokine with
direct antiviral activity, capable of promoting NK cells and
virus specific-T cells cytotoxicity, thus is considered an im-
portant molecule involved in antiviral host defense. Acting
via its receptor IFN-γ activates hundreds of genes leading
to pro-inflammatory effects by increasing antigen process-
ing and presentation, and anti-inflammatory effects due to
its apoptotic and anti-proliferative functions. IFN-γ may
interact with the airway epithelium triggering specific re-
ceptors, and leading to reduction in STAT6 phosphoryl-
ation [18]. In the mouse model of asthma IFN-γ signaling
through the airway epithelium inhibited mucus and chiti-
nases production, and systemic eosinophilia independent
of Th2 cell activation, suggesting its potential role in the
modulation of asthmatic inflammation [19]. IFN-γ, has
been considered to be mainly of lymphoid origin (pro-
duced mainly by T cells and natural killer cells) and rela-
tively few studies investigated expression of IFN-γ by the
airway epithelial cells [20].
Having in mind, the lack of experimental data on the
HPIV interaction with the upper airway epithelial cells,
and the paucity of information on the immune responses
of the airway epithelium to HPIV3 infection, we employed
human upper epithelial cell line (RPMI 2650) culture
model to study virus-induced production of IFN-γ and
pro-inflammatory cytokines.
Materials and methods
Cell and viral culture
Human nasal epithelial cells RPMI 2650 were obtained
from the American Type Culture Collection (ATCC,
Manassas, VA, USA). The cells were cultured in Eagle’s
Minimum Essential Medium with Earle’s salt (Sigma, St.
Louis, MO, USA), supplemented with 2 mM L-glutamine(Sigma), 10% fetal bovine serum (FBS, Invitrogen, Life
Technologies, CA, USA) and penicillin 100 U/mL (Sigma),
streptomycin 100 μg/mL (Sigma), amphotericin B 2.5 μg/mL
(Sigma) at 37°C with 5% CO2 in humidified air. The cul-
ture medium was changed every 48 hours. The cells were
seeded in 25 cm2 or 75 cm2 polystyrene cell-culture flasks
(Becton Dickinson Ltd, Oxford, U.K) and were grown to
90% confluence. When cells reached confluence they were
trypsinized with 0.1% trypsin-EDTA solution (Sigma) and
cells were transferred to 24-well culture plates (BD Ltd)
for further experiments.
HPIV type 3 was obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA) and prop-
agated in monkey kidney-derived LLC-MK2 cells (ATCC,
Manassas, VA, USA). Viral stocks were prepared by infect-
ing monolayer cultures of LLC-MK2 cells until cytopathic
effects (CPE) were fully developed. Viral supernatant fluid
was collected by centrifugation at 3000 rpm (960 × g) in
an Eppendorf 5810R centrifuge (Eppendorf, Hamburg,
Germany) equipped with an A-4-62 rotor (Eppendorf)
for 10 min to clear cellular debris and frozen in aliquots
at −80°C. All infections were performed on LLC-MK2 cell
monolayers in serum-free medium. Virus titers were de-
termined based on the 50% tissue culture infective dose
(TCID50) assay by infecting LLC-MK2 cells with serial
10-fold dilutions of each virus stock. Infected cells were
incubated at 37°C and CPE monitored on a daily basis.
The TCID50 was calculated using the method of Reed and
Muench. CPE was assessed by visual assessment and by
assessment of the continuity of the monolayer after fix-
ation in methanol (Sigma) and staining with 0.1% crystal
violet (Sigma).
Infection of cells with PIV3
RPMI 2650 cells cultured into confluence were placed in
medium without serum or additives and then infected with
PIV3 at multiplicities of infection (MOI) ranging from
0.001 to 1. After 1 h of incubation at room temperature,
the inoculum was removed, and the cells were further cul-
tured with MEM supplemented with 2% FCS. The cells or
supernatants were harvested at relevant time point. The
virus CPE and viability of infected cells were assessed 4, 8,
24, 48 and 72 h after infection.
Viability assay
Cell viability was assessed using the MTT assay. The
RPMI 2650 cells were trypsinized, replated in 96-well
plates and allowed to attach overnight. Fresh medium
containing PIV3 was added to the cells. On specified time
points, the culture media was removed, and MTT [thiazo-
lyl blue tetrazolium bromide, 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide] (Sigma) was added
to each well and the plates were incubated at 37°C for 3 h.
The reaction was stopped and after removing the medium,
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lium. The absorbance at 570 nm was determined using an
ELISA plate reader. Each assay point was performed in
triplicate and the assays were performed on at least three
separate occasions with similar results.
Measurement of mediators
TNF-α, IL-10, TSLP, IL-8, RANTES, eotaxin, GM-CSF
and IFN-γ levels were measured in cell supernatants 24,
48 and 72 h after infection with HPIV3 (MOI of 0.001,
0.01 and 0.1) by commercially available ELISA kits
(R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s specifications.
The sensitivity of the immunoassays was as follows:
RANTES 3 pg/ml; IL-10 3.9 pg/mL, TSLP 9.87 pg/mL,
IL-8 1.5-7.5 pg/mL; eotaxin 5 pg/mL; GM-CSF 3 pg/mL,
IFN-γ 1.8 pg/mL.
Real time PCR
Expression of cytokine mRNA in RPMI 2650 cells was
evaluated after reverse transcription with real-time poly-
merase chain reactions. Total cellular RNA was extracted
from epithelial cells using RNeasy mini kit (Qiagen, Lim-
burg, Holand) and reverse transcription was performed
with Omniscript RT kit (Qiagen). Real-time fluorescent
detection PCR product analysis was performed by using
iQ SYBR-Green Supermix (Bio-Rad, Hercules, CA, USA)
according to instrument recommendations (StepOnePlus
Real Time PCR System, Applied Biosystems, Carlsbad,
California). PCR amplification of cDNA was performed in
a reaction mixture containing 1 μL cDNA, 1 μL forward
and 1 μL reverse primers, 7 μL H2O and 10 μL iQ SYBR
GreenSupermix in a total volume of 20 μL. Reaction con-
ditions were as follows: 95°C for 5 min, followed by 35
cycles of 95°C for 30 sec, 35 cycles of different tempera-
tures for 1 min and 35 cycles of 72°C for 1 min. Annealing
temperatures were as follows: 60°C for IFN-γ and 61°C for
RANTES. Relative quantification of different transcripts
was determined with the 2−ΔΔCT method using β-actin as
an endogenous control.
Primers specific for RANTES and IFN-γ were pur-
chased from Eurogentec (Eurogentec, Liege, Belgium).
The sequences of the primers were as follows: RANTES:
Forward 5′- CGC TGT CAT CCT CAT TGC TA -3′,
Reverse 5′-GAG CAC TTG CCA CTG GTG TA-3′;
IFN-γ: Forward 5′-ATA TTG CAG GCA GGA CAA
CC-3′, Reverse 5′-TCA TCC AAG TGA TGG CTG AA-
3′; β-actin: Forward 5′- AGA AGG ATT CCT ATG TGG
GCG-3′, Reverse 5′- CAT GTC GTC CCA GTT GGT
GAC-3′.
Statistical data analysis
Data are presented as means and standard errors of the
means. Statistical analyses of the mediator concentrationswere performed using Kruskal-Wallis ANOVA, followed
by Wilcoxon matched-pairs signed-rank test. Alterna-
tively, Mann–Whitney U test was performed. Subsequent
post hoc analysis was conducted using the Bonferroni-
adjusted α method. All statistical analyses were performed
using Statistica version 10 (StatSoft Inc.). Values of p lower
than 0.05 were considered as statistically significant.
Ethics statement
The study was approved by ethics committee of the Medical
University of Lodz (RNN/121/12/KE 19/06/2012).
Results
HPIV3 cytotoxicity for RPMI 2650 cells
To determine whether HPIV3 replication in RPMI 2650
cells had any cytotoxic or cytopathic effect, cell cultures
were infected with the virus and observed using an
inverted microscope for the development of cytopathic
effect up to 96 h post inoculation (p.i.). Any cytopathic
effect (rounding, bridging, cell lysis, and syncytium for-
mation) was observed after 72 h and at the highest MOI
of 1. (Figure 1) When monolayers were stained with
crystal violet, no disruption of the cell layer could be ob-
served before 72 h. In order to assess the effect of virus
infection on cells’ viability, the culture media was re-
moved at specified time points, and MTT was added to
each well. At 24, 48 and 72 h there was no difference in
cell viability between the infected (MOI of 0.0001, 0.001,
0.01, and 0.1) and uninfected cells (Figure 2). Decreased
cell viability occurred at 72 h after virus infection at 1
MOI and this effect was pronounced 96 h after infec-
tion. Based on these experiments optimal MOI and time
points were chosen for further experiments.
Cytokine release and expression in nasal epithelial cells in
response to HPIV3 infection
IFN-γ protein was detected in non-infected cell superna-
tants at 24 h (mean concentration 3.2 ± 1.2 pg/mL), 48 h
(mean 2.8 ± 0.9 pg/mL) and 72 h (mean 2.9 ± 1.9 pg/mL).
PIV3 infection significantly increased in IFN-γ protein
level at 24 (by mean 387%) and 48 h (by mean 485%), post
infection but the level significantly decreased at 72 h.
Figure 3A The increase in the IFN-γ protein concentration
at 24 h was significant for all three MOI as compared
to mock infected cells (for MOI 0,001 - mean 10.2 ±
3.1 pg/mL, MOI 0,01 - mean 12.4 ± 2.9 pg/mL and MOI
0,1- mean 14,8 ± 2.3 pg/mL) Figure 3B.
IFN-γ mRNA expression increased significantly at
24 h by 174% over non-infected control and then de-
creased as compared to control by 28% and 66% at 48 h
and 72 h after infection respectively. Figure 3C.
Out of 7 cytokines measured in HNECs supernatants
after HPIV3 infection only RANTES protein was detect-
able. No measurable concentrations of TNF-α, IL-10, IL-8,
A. Uninfected cells B. 24h  C. 48h D. 72h E. 96h
Figure 1 Confluent RPMI 2650 cells monolayers under the light microscope (100x). A. non-infected; B, C, D, E – infected with PIV3 at an
MOI of 0.1 at different time-points.
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fected and virus-infected cells supernatants.
RANTES protein was undetectable in supernatants col-
lected at 24 h, but was detected at 48 h in supernatants
from uninfected and PIV3 infected cells (0.1MOI) (mean
concentration 6.1 ± 3.2 pg/mL and 7.5 ± 2.1 pg/mL) and
significantly increased at 72 h p.i. (mean concentration
61.5 ± 18.4 pg/mL as compared to 9.3 ± 2.8 pg/mL in non-
infected cells). Figure 4A The increase in RANTES protein
release at 72 h was virus dose-dependent. Figure 4B.
RANTES mRNA expression slightly increased already at
24 h (mean 15% increase over non-infected control) and
at 48 h (mean 51% increase), but was significantly aug-
mented (mean 184% increase) at 72 h Figure 4C.
Discussion
Our study demonstrated for the first time, that human
airway epithelial cells may generate IFN-γ in response to
virus infection. Generation of IFN-γ by epithelial cells
tended to be virus dose-dependent and the maximal sig-
nal for IFN-γ mRNA expression was observed already at
24 h after infection together with significant increase in
IFN-γ protein concentration in the cell supernatant.
Interestingly, IFN-γ protein concentration decreased to
baseline level at 72 h post infection in parallel to de-
creased IFN-γ mRNA expression. At 72 h post infectionFigure 2 Cell viability changes of PIV3-infected RPMI 2650 cells. Cells
different MOI for indicated hours. Cell viability was detected by MTT assay.the cells maintained full viability and RANTES expres-
sion reached the highest value, indicating that the IFN-γ
generation was a truly transient phenomenon. Our ob-
servations contrast with previous study that failed to de-
tect IFN-γ mRNA expression or IFN-γ protein secretion
in primary human airway epithelial cells in response to
rhinovirus (RV16) infection [14]. However, IFN-γ was
shown to be expressed in the alveolar cell line A549
after bacterial infections: IFN-γ mRNA expression was
detected in cells infected with Mycoplasma pneumoniae
and Chlamydia pneumoniae [21,22] and release of high
concentrations of IFN-γ was shown in A549 cells in-
fected with Mycobacterium tuberculosis [20]. These ob-
servations suggest, that IFN-γ generation by airway
epithelial cells may depend on the infecting pathogen
and/or on the epithelial cell line tested. In an ex vivo
study, IFN-γ expression in PBMC of infants varied sig-
nificantly depending on the nature of the viral pathogen
(parainfluenza, rhinovirus, adenovirus or RSV) and se-
verity of clinical illness [23]. Differential capacity of re-
spiratory viruses to generate IFN-γ response in the
airway epithelial cell may be important to determine
their ability to promote Th1 immune response, which
especially in infants may have consequences for develop-
ment of allergic sensitization and asthma later in life.
While these observations require to be confirmed in thewere seeded into 24-well culture plates and infected with PIV3 at
(n = 10).
Figure 3 PIV-3 induced IFN-γ protein release and mRNA
expression in RPMI 2650 cells (n = 8; the results are expressed
as mean +/− SEM; * p < 0.05). A. Time course of PIV-3 (0.1 MOI)
induced IFN-γ protein release. B. Effect of increasing PIV-3 MOI on
IFN-γ protein release at 24 h p.i. C. Time course of PIV3 (0.1MOI)
induced IFN-γ mRNA expression.
Figure 4 PIV-3 induced RANTES protein release and mRNA
expression in RPMI 2650 cells (n = 8; the results are expressed
as mean +/− SEM; * p < 0.05). A. Time course of PIV-3 (0.1MOI)
induced RANTES protein release. B. Effect of increasing PIV-3 MOI on
RANTES protein release at 72 h p.i. C. Time course of PIV3 (0.1MOI)
induced RANTES mRNA expression.
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implications for our understanding of the pathophysi-
ology of PIV-3 induced respiratory infection. IFN-γ in-
duces genes promoting antiviral mechanisms, which
include leukocyte recruitment, antigen processing and
presentation, cell proliferation and apoptosis, leading to
limitation of the viral infection and its consequences
[24]. IFN-γ actions through the airway epithelium has
been shown to inhibit eosinophil generation in the bonemarrow, limiting airway obstruction and inflammation
in the animal model of asthma [19]. Thus, induced by
virus generation of IFN-γ in epithelial cells must be con-
sidered as a component of natural host defense counter-
acting induction of pro inflammatory mediators and
leading to limitation of the tissue destruction. IFN-γ
may act in concert with type I (IFN-α, IFN-β) and type
III (IFN-λ) interferons, which are generated in response
to viral infections in upper and lower airway epithelial
cells and may limit virus-induced injury [17,25].
On the other hand it has been documented, that local
production of IFN-γ as well as other proinflammatory
cytokines (CCL3, CCL 11) in the lungs of mice infected
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severity of the lung disease [26]. In cotton rat model of
Human Parainfluenza 3 laryngotracheitis IFN-γ mRNA
expression in laryngeal tissues was increased by infection
and corticosteroid treatment, which reduced the extent
of lesions, led to a measurable reduction of IFNγ expres-
sion [27]. Accordingly in children with croup parenteral
dexamethasone or inhaled budesonide are used in the
early treatment of the diseases, and effectiveness of GCS
has been associated with decreased IFN-γ mRNA ex-
pression [28]. Thus, further studies with specific inhibi-
tors of IFN-γ have to be carried out to elucidate if virus
induced IFN-γ generation by epithelial cells has pro or
anti-inflammatory function.
HPIV3 has been shown to exacerbate preexisting asthma
presumably by setting off the inflammatory cascade with
generation of other than IFN-γ mediators and cytokines
[7,8,29]. In human upper airway epithelial cell line infected
with HPIV3 out of 7 cytokines measured only RANTES
could be detected in the supernatants. A significant in-
crease in RANTES protein was observed at 72 h, when
IFN-γ concentration was already decreased. The induction
of high RANTES levels in PIV3 infected of upper airway
epithelial cells is consistent with other studies on bronchial
epithelial cell monolayers infected with HPIVs and other vi-
ruses from Paramyxoviridae family [15,30,31]. In human
ciliated airway epithelium infected with PIV3 RANTES
concentrations increased gradually from day 2 through day
5 post infection [15]. Increased RANTES secretion was also
found after RSV infection in bronchial epithelial cells
[30,31] and elevated RANTES levels were reported in naso-
pharyngeal secretions from RSV-positive children [32].
Local production of chemokines has been also observed in
children with PIV-positive airway respiratory infections:
PIV-infected patients had higher nasal wash concentrations
of chemokines such as RANTES/CCL5, IL-8/CXCL8, MIP-
1 α/CCL3, MIP-1 β/CCL4, CXCL9 and CXCL10 as com-
pared to uninfected control patients [33]. Production of
pro-inflammatory chemokines by HPIV3 infected air-
way epithelial cells may contribute to development of
respiratory symptoms in infected healthy individuals,
but may also contribute to the exaggerated host inflam-
matory response associated with virus - induced exacer-
bations of chronic inflammatory airways diseases .
Although we were not able to detect any measurable
concentrations of TNF-α, IL-10, IL-8, exotaxin, GM-CSF
and TSLP in either uninfected and virus-infected cells
supernatants our data cannot be directly referred to
in vivo studies. For example, the release of cytokines and
chemokines from airway epithelial cells is strongly af-
fected by the presence of T lymphocytes, which may be
responsible for less cytokine generation in isolated cell
line model [34]. Furthermore, cytokine production in
response to virus infection is both virus and cell typespecific and even the same virus may evoke various cyto-
kine response in upper and upper and lower primary hu-
man epithelial cells [35]. Thus, is also possible that the
lack of production of some proinflammatory cytokines
in our model results either from not sufficient activation
of cells by PIV3 or reflect specific type o response to
HPIV3 virus in RPMI cell line.
RPMI 2650 cell line used in this study have been
shown to closely resemble normal human upper airway
epithelium with respect to its karyotype, cytokeratin ex-
pression and the presence of mucoid material on the cell
surface, and were previously used to study interactions
of the airway epithelium with cytokines and allergens
[36-38]. This is the first study documenting in vitro in-
fection of human nasal epithelial cells (RPMI 2650 line)
with HPIV3, and its association with the release of cyto-
kines; in all previous studies only HPIV infections of
lower airway epithelium have been examined [15,16,39].
In our model HNECs infected with HPIV3 did not show
apparent cytopathology for up to 92 h after infection,
and cells viability was not changed up to 48 h, and at
72 h only with the highest virus titres was significantly
decreased. These results are consistent with observations
of Zhang et al [39,40]. who during the lower airway epi-
thelial cells culture, grown at an air-liquid interface, ob-
served little PIV3 virus cytotoxicity.
In conclusion we have demonstrated that HPIV3 effect-
ively infects upper airway epithelial cells and the infection
is associated with induction of interferon gamma. Further
investigations involving primary human cells and IFN-γ
inhibitors may allow for understanding the role of the epi-
thelium derived IFN-γ in the pathophysiology of HPIV3
induced and/or exacerbated respiratory disorders.
Abbreviations
HPIVs: Human parainfluenza viruses; PIV3: Parainfluenza virus type 3;
HPIV3: Human parainfluenza virus type 3; RSV: Respiratory syncytial virus;
HNECs: Human nasal epithelial cells.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ALP designed, performed and analyzed all the experiments and prepared
the manuscript. EP, ZL assisted in data analysis and preparation of the
manuscript. MB, MJ, SM, performed experiments. MK performed experiments
and assisted in data analysis. MLK designed experiments, supervised all
aspects of the project and prepared the manuscript. All authors read and
approved the final manuscript
Acknowledgments
The study was supported by the Maestro Grant from the National Research
Center (Grant Nr UMO-2011/02/A/NZ5/00341). The authors have been
partially supported by The Healthy Aging Research Center project
(REGPOT-2012–2013-1, 7FP).
Author details
1Department of Immunology, Rheumatology and Allergy, Chair of Clinical
Immunology and Microbiology, Medical University of Lodz, Lodz, Poland.
2Department of Microbiology, Immunology and Laboratory Medicine, Chair
of Clinical Immunology and Microbiology, Medical University of Lodz, Lodz,
Lewandowska-Polak et al. Journal of Inflammation  (2015) 12:16 Page 7 of 7Poland. 3Laboratory of Molecular Virology and Biological Chemistry, Institute
of Medical Biology, Polish Academy of Sciences, Lodz, Poland. 4Healthy
Ageing Research Centre, Medical University of Lodz, Lodz, Poland.
Received: 17 July 2014 Accepted: 20 January 2015References
1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med.
2001;344:1917–28.
2. Frost HM, Robinson CC, Dominguez SR. Epidemiology and clinical
presentation of parainfluenza type 4 in children: a 3-year comparative study
to parainfluenza types 1–3. J Infect Dis. 2014;209:695–702.
3. Liu WK, Liu Q, Chen DH, Liang HX, Chen XK, Huang WB, et al. Epidemiology
and clinical presentation of the four human parainfluenza virus types.
BMC Infect Dis. 2013;13:28.
4. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003;16:242–64.
5. Laurichesse H, Dedman D, Watson JM, Zambon MC. Epidemiological
features of parainfluenza virus infections: laboratory surveillance in England
and Wales, 1975–1997. Eur J Epidemiol. 1999;15:475–84.
6. Mizuta K, Saitoh M, Kobayashi M, Tsukagoshi H, Aoki Y, Ikeda T, et al.
Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein
gene in human parainfluenza virus type 1 isolates from patients with acute
respiratory infection between 2002 and 2009 in Yamagata prefecture. Japan
Virol J. 2011;8:533.
7. Azevedo AM, Durigon EL, Okasima V, Queiroz DA, de Moraes-Vasconcelos D,
Duarte AJ, et al. Detection of influenza, parainfluenza, adenovirus and
respiratory syncytial virus during asthma attacks in children older than
2 years old. Allergol Immunopathol (Madr). 2003;31:311–7.
8. Matsuse H, Kondo Y, Saeki S, Nakata H, Fukushima C, Mizuta Y, et al.
Naturally occurring parainfluenza virus 3 infection in adults induces mild
exacerbation of asthma associated with increased sputum concentrations of
cysteinyl leukotrienes. Int Arch Allergy Immunol. 2005;138:267–72.
9. Schomacker H, Schaap-Nutt A, Collins PL, Schmidt AC. Pathogenesis of
acute respiratory illness caused by human parainfluenza viruses. Curr Opin
Virol. 2012;2:294–9.
10. Wang JH, Kwon HJ, Jang YJ. Detection of parainfluenza virus 3 in turbinate
epithelial cells of postviral olfactory dysfunction patients. Laryngoscope.
2007;117:1445–9.
11. Message SD, Johnston SL. Host defense function of the airway epithelium in
health and disease: clinical background. J Leukoc Biol. 2004;75:5–17.
12. Schroth MK, Grimm E, Frindt P, Galagan DM, Konno SI, Love R, et al.
Rhinovirus replication causes RANTES production in primary bronchial
epithelial cells. Am J Respir Cell Mol Biol. 1999;20:1220–8.
13. Terajima M, Yamaya M, Sekizawa K, Okinaga S, Suzuki T, Yamada N, et al.
Rhinovirus infection of primary cultures of human tracheal epithelium: role
of ICAM-1 and IL-1beta. Am J Physiol. 1997;273:L749–59.
14. Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D, et al. Rhinovirus
induces airway epithelial gene expression through double-stranded RNA
and IFN-dependent pathways. Am J Respir Cell Mol Biol. 2006;34:192–203.
15. Schaap-Nutt A, Liesman R, Bartlett EJ, Scull MA, Collins PL, Pickles RJ, et al.
Human parainfluenza virus serotypes differ in their kinetics of replication
and cytokine secretion in human tracheobronchial airway epithelium.
Virology. 2012;433:320–8.
16. Bartlett EJ, Hennessey M, Skiadopoulos MH, Schmidt AC, Collins PL, Murphy
BR, et al. Role of interferon in the replication of human parainfluenza virus
type 1 wild type and mutant viruses in human ciliated airway epithelium.
J Virol. 2008;82:8059–70.
17. Okabayashi T, Kojima T, Masaki T, Yokota S, Imaizumi T, Tsutsumi H, et al.
Type-III interferon, not type-I, is the predominant interferon induced by
respiratory viruses in nasal epithelial cells. Virus Res. 2011;160:360–6.
18. Moynihan BJ, Tolloczko B, El Bassam S, Ferraro P, Michoud MC, Martin JG,
et al. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway
smooth muscle cells to IL-13. Respir Res. 2008;9:84.
19. Mitchell C, Provost K, Niu N, Homer R, Cohn L. IFN-gamma acts on the
airway epithelium to inhibit local and systemic pathology in allergic airway
disease. J Immunol. 2011;187:3815–20.
20. Sharma M, Sharma S, Roy S, Varma S, Bose M. Pulmonary epithelial cells are
a source of interferon-gamma in response to Mycobacterium tuberculosis
infection. Immunol Cell Biol. 2007;85:229–37.21. Yang J, Hooper WC, Phillips DJ, Talkington DF. Regulation of
proinflammatory cytokines in human lung epithelial cells infected with
Mycoplasma pneumoniae. Infect Immun. 2002;70:3649–55.
22. Yang J, Hooper WC, Phillips DJ, Tondella ML, Talkington DF. Induction of
proinflammatory cytokines in human lung epithelial cells during Chlamydia
pneumoniae infection. Infect Immun. 2003;71:614–20.
23. Aberle JH, Aberle SW, Rebhandl W, Pracher E, Kundi M, Popow-Kraupp T.
Decreased interferon-gamma response in respiratory syncytial virus
compared to other respiratory viral infections in infants. Clin Exp Immunol.
2004;137:146–50.
24. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview
of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163–89.
25. Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, Contoli M,
et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in
bronchial epithelial cells and peripheral blood mononuclear cells. Allergy.
2009;64:375–86.
26. Suryadevara M, Bonville CA, Rosenberg HF, Domachowske JB. Local
production of CCL3, CCL11, and IFN-gamma correlates with disease severity
in murine parainfluenza virus infection. Virol J. 2013;10:357.
27. Ottolini MG, Porter DD, Blanco JC, Prince GA. A cotton rat model of human
parainfluenza 3 laryngotracheitis: virus growth, pathology, and therapy.
J Infect Dis. 2002;186:1713–7.
28. Hu X, Li WP, Meng C, Ivashkiv LB. Inhibition of IFN-gamma signaling by
glucocorticoids. J Immunol. 2003;170:4833–9.
29. Takeyama A, Hashimoto K, Sato M, Sato T, Tomita Y, Maeda R, et al.
Clinical and epidemiologic factors related to subsequent wheezing after
virus-induced lower respiratory tract infections in hospitalized pediatric
patients younger than 3 years. Eur J Pediatr. 2014;173:959–66.
30. Yoon JS, Kim HH, Lee Y, Lee JS. Cytokine induction by respiratory syncytial
virus and adenovirus in bronchial epithelial cells. Pediatr Pulmonol.
2007;42:277–82.
31. Villenave R, O’Donoghue D, Thavagnanam S, Touzelet O, Skibinski G,
Heaney LG, et al. Differential cytopathogenesis of respiratory syncytial virus
prototypic and clinical isolates in primary pediatric bronchial epithelial cells.
Virol J. 2011;8:43.
32. Murai H, Terada A, Mizuno M, Asai M, Hirabayashi Y, Shimizu S, et al. IL-10
and RANTES are elevated in nasopharyngeal secretions of children with
respiratory syncytial virus infection. Allergol Int. 2007;56:157–63.
33. El Feghaly RE, McGann L, Bonville CA, Branigan PJ, Suryadevera M,
Rosenberg HF, et al. Local production of inflammatory mediators during
childhood parainfluenza virus infection. Pediatr Infect Dis J. 2010;29:e26–31.
34. Jornot L, Cordey S, Caruso A, Gerber C, Vukicevic M, Tapparel C, et al. T
lymphocytes promote the antiviral and inflammatory responses of airway
epithelial cells. PLoS One. 2011;6:e26293.
35. Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. In vitro
susceptibility to rhinovirus infection is greater for bronchial than for nasal
airway epithelial cells in human subjects. J Allergy Clin Immunol.
2009;123:1384–90. e1382.
36. Pace E, Scafidi V, Di Bona D, Siena L, Chiappara G, Ferraro M, et al. Increased
expression of IL-19 in the epithelium of patients with chronic rhinosinusitis
and nasal polyps. Allergy. 2012;67:878–86.
37. Reichl S, Becker K. Cultivation of RPMI 2650 cells as an in-vitro model for
human transmucosal nasal drug absorption studies: optimization of selected
culture conditions. J Pharm Pharmacol. 2012;64:1621–30.
38. Salib RJ, Lau LC, Howarth PH. The novel use of the human nasal epithelial
cell line RPMI 2650 as an in vitro model to study the influence of allergens
and cytokines on transforming growth factor-beta gene expression and
protein release. Clin Exp Allergy. 2005;35:811–9.
39. Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, et al.
Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro
model of human airway epithelium. J Virol. 2005;79:1113–24.
40. Zhang L, Collins PL, Lamb RA, Pickles RJ. Comparison of differing cytopathic
effects in human airway epithelium of parainfluenza virus 5 (W3A),
parainfluenza virus type 3, and respiratory syncytial virus. Virology.
2011;421:67–77.
